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Abstract The purpose of this study was to evaluate
computed analysis of three-dimensional (3D) cone-beam
computed tomography angiography (CTA) of the liver for
determination of subsegmental tumor-feeding vessels
(FVs). Eighteen consecutive patients underwent transarte-
rial chemoembolization (TACE) from January to October
2008 for 25 liver tumors (15 hepatocellular carcinomas
[HCCs] and 10 neuroendocrine metastases). Anteroposte-
rior projection angiogram (two-dimensional [2D]) and 3D
cone-beam CTA images were acquired by injection of the
common hepatic artery. Retrospectively, FVs were inde-
pendently identified by three radiology technologists using
a software package (S) that automatically determines FVs
by analysis of 3D images. Subsequently, three interven-
tional radiologists (IRs) independently identified FVs by
reviewing the 2D images followed by examination of the
3D images. Finally, the ‘‘ground truth’’ for the number and
location of FVs was obtained by consensus among the IRs,
who were allowed to use any imaging¯including 2D, 3D,
and all oblique or selective angiograms¯for such determi-
nation. Sensitivities, durations, and degrees of agreement
for review of 2D, 3D, and S results were evaluated. Sen-
sitivity of 3D (73%) was higher than 2D (64%) images for
identification of FVs (P = 0.036). The sensitivity of S
(93%) was higher than 2D (P = 0.02) and 3D (P = 0.005)
imaging. The duration for review of 3D imaging was
longer than that for 2D imaging (187 vs. 94 s, P = 0.0001)
or for S (135 s, P = 0.0001). The degree of agreement
between the IRs using 2D and 3D imaging were 54% and
62%, respectively, whereas it was 82% between the three
radiology technologists using S. These preliminary data
show that computed determination of FVs is both accurate
and sensitive.
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Introduction
Transarterial chemoembolization (TACE) is a palliative
treatment for patients with hepatocellular carcinoma
(HCC) who are not candidates for transplantation, surgical
resection, or radiofrequency ablation [1]. TACE is also
used for the treatment of select hypervascular liver
metastases, such as those of neuroendocrine origin [2]. This
minimally invasive procedure allows delivery of a high
concentration of particles and/or chemotherapeutic agents
into the liver, causing ischemic cell death and permitting
local delivery of high concentrations of chemotherapeutic
drug. Selective administration of chemoembolic material to
the tumor is desired, where possible, to increase the
effectiveness of treatment to the tumor and minimize injury
to surrounding liver tissue [3].
Visualization of the liver arterial tree during TACE has
until recently been guided by two-dimensional (2D) angio-
gram. Two-dimensional projections depict hepatic arteries
superimposed on one another, leading to the potential for
misinterpretation of which arteries (i.e., feeding vessels
[FVs]) supply the tumor. Consequently, there is a potential
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for incorrect or suboptimal catheter position for treatment.
This limitation has traditionally been overcome by acqui-
sition of multiple selective injections and oblique projec-
tions for precise analysis of the anatomy of the liver arterial
tree to determine FVs. This approach, although time tested
and valid, increases procedural time, administered contrast
volumes, and radiation doses.
A relatively new approach is to use three-dimensional
(3D) cone-beam computed tomography angiography
(CTA), a technique that permits assessment of complex
vascular anatomy after a single injection of contrast medium
in a main hepatic artery. Recently, several studies have
shown that the use of 3D CTA can be extremely helpful
during TACE, especially in cases of complex hepatic arterial
anatomy [4–6]. However, the time requirements for pro-
cessing and evaluating 3D CTA models may discourage its
routine use by interventional radiologists (IRs), who are
accustomed to performing hepatic arterial interventions on
the basis of conventional angiographic projections. In
addition, evaluation of 3D CTA models requires either a
sterile remote control for in-room review or the IR’s exit
from the angiographic room to access a workstation. We
developed a software program (S), designed to automati-
cally determine FVs from 3D CTA images. The purpose of
this study was to evaluate IR analysis of 3D data using S for
determination of FVs, in terms of sensitivity, interoperator
concordance, and duration, compared with analysis using
2D and 3D images.
Materials and Methods
Patients
From January 2008 to October 2008, 18 consecutive
patients (12 men and 6 women; mean age 65 years [range
40–75]) were referred for 1 session of subsegmental TACE
after evaluation by the multidisciplinary team at our hos-
pital. Twelve patients had HCC, and 6 patients had liver
metastases from neuroendocrine tumors. These 18 patients
had 25 total unresectable liver tumors (1–3 tumors/patient),
including 15 HCCs and 10 metastases from neuroendocrine
tumors, measuring 21–96 mm (mean 44).
Angiogram Acquisition
TACE was performed with the patient under local anes-
thesia and conscious sedation using commercially available
flat-panel detectors (Innova 4100; GE Healthcare, Chalfont
St Gilles, UK). A 5F vascular sheath was inserted into the
right femoral artery, and a 5F Cobra catheter (Cook;
Bjaeverskov, Denmark) and a 0.035 hydrophilic guidewire
(Terumo, Tokyo, Japan) were used to cannulate the
common hepatic artery. All patients had a single hepatic
artery feeding the liver, and no patient had a replaced
hepatic artery. The 2D and 3D images were acquired
during injection of contrast media (Visipaque 320mgI/ml;
GE Healthcare) through the 5F catheter in the common
hepatic artery after elevating the patient’s arms above the
head and asking him or her to breath-hold. For the 2D
images, 15 ml contrast media was injected at a flow rate of
3 ml/s, and the frame rate was 2 images/s (Fig. 1). For the
3D cone-beam CTA images, 24 ml contrast media was
injected at a flow rate of 3 ml/s, and the injection started
3 s before start of the C-arm rotation and continued during
the 5 s of the rotation. The C-arm rotated 200 around the
patient at a rate of 40/s for 5 s. A series of 148 images was
acquired at a rate of 30 frames/s. The reconstructed 3D
field of view was 23 9 23 9 23 cm, and the matrix size
was 512 9 512 9 512 (Fig. 2). The time of automatic
reconstruction of the 3D images, starting from the end of
the rotational acquisition, was 50 s. A 2.4F or 2.7F mi-
crocatheter (Progreat; Terumo, Tokyo, Japan) was used to
perform additional selective angiograms and subsegmental
TACE. Additional selective angiograms at various angles
were performed at the discretion of the operators according
to the treatment needs of the patient (Figs. 3, 4).
Software Analysis Methodology
Institutional Review Board approval was obtained for an
IR or X-ray technician (XRT) to retrospectively review
cone-beam CTA data and imaging files to determine the
Fig. 1 Two-dimensional image of a large endocrine metastatic liver
tumor, obtained after injection in the common hepatic artery, shows a
large tumor blush in the right lobe of the liver
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ability of 2D, 3D, and S analysis to determine subseg-
mental FVs of liver tumors.
Software
S was used on a workstation (ADW4.4; GE Healthcare,
Chalfont St Gilles, UK) to analyze 3D imaging data
(Fig. 5). For each tumor, determination of FVs was based
on three consecutive steps, structure extraction, target
definition, and FV selection, as follows:
• Structure Extraction: A seed point is manually defined
by the XRT at the entrance of the hepatic artery on any
image from the multiplanar reconstruction (MPR). S
performs a simple histogram analysis to determine
voxel intensities typical of soft tissue and injected
vessels. Because injected vessels and bones intensities
overlap, seed points are automatically determined by
thresholding high-intensity voxels within a neighbor-
hood of the spine. Concurrent intensity-based segmen-
tation is also performed. Based on connectivity to the
seeds, two masks are obtained that divide the hepatic
arterial tree and the bony structures (spine and ribs).
These masks are displayed using volume rendering
(Fig. 6). As a result, it is easier to read the image when
nonrelevant structures are cleaned out.
• Target Definition: The user adjusts a spherical region of
interest (ROI) around the targeted tumor. This adjust-
ment can be performed on any MPR image (Figs. 7, 8).
• FV Selection: S automatically considers all vessels in the
vicinity of the target as being FVs. Vicinity is automat-
ically determined by geometric considerations. S high-
lights all vessels (from the seed point to the tumor) that
appear to feed the tumor by coming into close geometric
proximity with the ROI (Fig. 9). FVs define a third mask,
which is vividly displayed on top of the previously
determined volume rendering of the vascular and bony
masks. Because bones have been distinguished from
vessels, they are displayed in a dimmer way and can be
hidden altogether if they are not useful for determining
the anatomic context (Figs. 10, 11).
To better understand the anatomic relation of the hepatic
branches, the display with highlighted FVs can be exam-
ined as a 3D volume. It is possible to repeat the second and
third steps to determine FVs for several tumors in the same
3D acquisition.
Fig. 2 Three-dimensional image of the same tumor obtained after
injection in the common hepatic artery
Fig. 3 Selective 2D angiogram of the same tumor with a
microcatheter
Fig. 4 Selective 2D angiogram of the same tumor with a
microcatheter
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Three X-ray technicians (XRT-1, XRT-2, and XRT-3),
with 8, 1, and 2 years of experience in vascular radiology,
respectively, were independently asked to define the
number and location of FVs for all tumors using S. They
were blind to any other imaging, including 2D and pre-
TACE imaging work-up. Consensus on each FV between
Fig. 5 Display of S on the workstation. The left upper quadrant
shows the volume-rendering reconstruction of the 3D image. The
different steps for FV extraction are visualized in the right upper
quadrant (corresponding to Figs. 6, 9, 10, and 11). The MPR in the
axial and coronal views used for determination of the tumor location
(corresponding to Figs. 7 and 8) are shown in the left lower quadrant
and right lower quadrant, respectively
Fig. 6 Two masks are obtained that divide the hepatic arterial tree
from the bony structures Fig. 7 Determination of tumor location using ROI the same diameter
as the tumor in the axial plane of the MPR
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the three XRTs was defined as agreement of at least two
XR-Ts regarding the FV.
2D and 3D Analysis
Three IRs (IR-1, IR-2, and IR-3), with 16, 5, and 5 years of
experience in vascular radiology, respectively (external to
the present cases), were independently asked to find the
number and location of subsegmental FVs for all tumors by
retrospectively reviewing first the 2D images only and then
the 3D images on a workstation. The IRs were blind to
additional angiograms (selective injections, oblique pro-
jections) performed during TACE. They had free access to
patient medical files, including pre-TACE CTA or mag-
netic resonance imaging), which were available for all
patients within the month before TACE was performed.
Consensus on each FV between the three IRs was defined
as agreement of at least two IRs regarding the FV.
Ground Truth and Statistical Analysis
The ‘‘ground truth’’ (GT) was defined, after the above-
mentioned analyses by the XRTs and IRs were complete,
Fig. 8 Determination of tumor location using ROI the same diameter
of the tumor in the coronal plane of the MPR
Fig. 9 FV highlighted in red by S
Fig. 10 Bones can be hidden for better understanding
Fig. 11 For better understanding, vessels that do not feed the tumor
can be hidden
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by consensus among the IRs, who were then allowed to use
global 2D and 3D images, as well S, in addition to all
additional angiograms acquired during TACE (Fig. 12) and
posttreatment follow-up (when available). GT was used to
define true-positive, false-positive, and false-negative FVs.
True-positive FVs for 2D, 3D, and S were subsegmental
liver vessels identified as tumor feeders on global 2D,
global 3D, or S analysis, respectively, that actually sup-
plied the target tumor. False-positive FVs were vessels
identified as tumor feeders on global 2D, global 3D, or S
analysis that did not actually feed the tumor. False-negative
FVs were vessels not identified as tumor feeders on global
2D, global 3D, or S analysis that actually did supply the
target tumor.
Sensitivity was calculated as the consensus of the true-
positive FVs on 2D, 3D, and S analysis divided by the
actual number of FVs on GT analysis. Sensitivities of 2D,
3D, and S analysis were compared using McNemar’s test
for matched proportions extended to clustered data to
account for within-patient correlation [7].
Specificity could not be ascertained because true-negative
FVs (vessels that neither supplied the tumor nor were identified
as FVs) were too numerous and could not be precisely counted.
Interoperator concordances were assessed for 2D, 3D,
and S analyses. Interoperator concordances for 2D and for
3D analyses were the percentage of subsegmental FVs found
by the IRs by analyzing global 2D and global 3D images.
Interoperator concordance for S data was the percentage of
subsegmental FVs found by the XRTs using S.
Mean durations of analyses of 2D and 3D images by the
IRs and mean duration of analyses using S by the XRTs
were compared using paired Student t test. All reported P-
values are two sided. Analyses were performed using SAS
statistical software (SAS, Cary, NC). The significance level
was 0.05 and was two sided.
Results
According to GT, the number of subsegmental FVs per
tumor varied from 1 to 6 (mean 3.3), and the total number
of subsegmental FVs for all 25 tumors was 83.
The numbers of subsegmental FVs, the percentage of
true-positive subsegmental FVs, and the percentage of
false-positive subsegmental FVs found by each IR ana-
lyzing 2D and 3D images and for each XRT are reported in
Table 1. Sensitivities and mean time required for 2D, 3D,
and S analysis are reported in Tables 2 and 3, respectively.
Fig. 12 GT was defined by consensus among the three IRs. FVs are
highlighted in red on a paper copy of the 2D angiogram
Table 1 True-positive, false-positive, and false-negative FVs detected by IRs using 2D and 3D imaging and XRTs using S software
Number of years of experience in vascular radiology IR-1 IR-2 IR-3 XRT-1 XRT-2 XRT-3
(16)a (5) (5) (18) (1) (2)
Total no. of subsegmental FVs depicted 70 45 64
70 57 69
82 87 84
No. of true-positive FVs detected 2D 59 38 52
3D 65 49 65
S software 75 77 77
No. of false-positive FVs detected 2D 11 7 12
3D 5 8 4
S software 7 10 7
No. of false-negative FVs detected 2D 24 45 31
3D 18 34 18
S software 8 6 6
Years of experience in vascular radiology
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Sensitivity was significantly higher when the IRs used the
3D angiogram compared with the conventional 2D angio-
gram (73% vs. 64%, P = 0.036). Sensitivities of S as used by
XRTs were 90%, 93%, and 93%, respectively (mean 93%),
all of which were significantly higher than analysis using 2D
(P = 0.002) and 3D (P = 0.0056) images by the IRs. Con-
cordances for the IRs were 54% using 2D and 62.5% using 3D
images. Concordance for the XRTs using S was 82.5%.
Mean duration of analyzing 3D images by IRs was
significantly higher than analyzing 2D (187 vs. 94 s,
P \ 0.0001) images. Durations using S by the XRTs were
138, 140, and 127 s (mean 135), respectively, which was
significantly less time than required for analysis of 3D
images (P \ 0.0001) but significantly more time than
required for analysis of 2D images (P \ 0.0001).
Discussion
The benefit of using 3D imaging during TACE has already
been demonstrated by several studies. First, Liapi et al. [4]
reported the usefulness of 3D during TACE in 2 patients
with HCC carcinoma having complex vascular anatomy.
They argued that in such cases, 3D imaging (1) decreased
contrast medium dose as well as radiation exposure for
patients and physicians by decreasing multiple 2D images
and (2) allowed treatment of hepatic tumors with complex
vascular anatomy that otherwise would have been difficult
to treat. Kakeda et al. [5] demonstrated that 3D imaging
provided clinically acceptable image quality in the
assessment of 52 HCCs and that in 81% of the cases it
provided additional information for treatment compared
with 2D imaging. Similarly, Miyayama et al. demonstrated
that 3D imaging was useful in detecting and treating small
HCC lesions that could not be demonstrated on angiogra-
phy [6]. Virmani et al. [7] showed that the results of 3D
imaging altered the choice of catheter position for deliv-
ering TACE, as anticipated by an attending IR, in 39% of
cases and improved the diagnostic confidence in selected
catheter positioning in 78% of cases.
Our study demonstrates that 3D imaging improves the
sensitivity for detecting FVs compared with 2D imaging
(73% vs. 64%, P = 0.036). Similarly, Iwazawa et al. reported
that the sensitivity of 3D to determine FVs was significantly
higher than that of 2D imaging (96.9% vs. 77.2%, P \ 0.01)
[8]. In our study, it is noteworthy that this superiority was
found by the three IRs who reviewed the cases, but the dif-
ference was significant only for the two IRs who had more
brief career experience (Table 1). A valid explanation for this
difference in sensitivity when IRs reviewed 2D imaging
could be that 2D analysis needs much more expertise in
interventional radiology than does 3D analysis. The gain in
sensitivity from 2D to 3D analysis is accompanied by an
increased amount of time required to review the 3D data.
Indeed, since its emergence in vascular radiology, 3D
imaging has been limited by the time required to incorporate
it into the fast pace of interventional procedures. Thus,
despite a gain in sensitivity, it has been challenging to use
routinely. Ideally, analysis of the 3D data set could be per-
formed by a third person, sparing the operating IR and patient
from procedural interruption. For this reason we asked the
XRT, not the operating IR, to analyze the S results.
Our study demonstrates that software dedicated to sub-
segmental FV analysis can be useful for the IR when
subsegmental TACE is considered. Using S improves
sensitivity and decreases the time to detect subsegmental
FVs compared with review of 3D imaging. Thus, S can
depict subsegmental FVs that the IR may not have per-
ceived by conventional angiography and increases confi-
dence in detecting suspicious subsegmental FVs. We
hypothesize that such software will decrease the need for
additional oblique and selective angiograms, thus
decreasing the volume of contrast media and radiation
exposure of both the patient and the IR. However, these
factors were not evaluated in this study.
Table 2 Sensitivity of 2D, 3D, and S software analysis
Sensitivity (%) IR-1 IR-2 IR-3 IR
consensus
Number of years
of experience in
vascular
radiology
(16)a (5) (5)
2D 71 63 46 64
3D 78 78 59 73
S software
(median)
93
3D vs. 2D P = 0.19 P = 0.008 P = 0.005 P = 0.036
S vs. 2D P = 0.003 P = 0.0002 P = 0.002 P = 0.0024
S vs. 3D P = 0.026 P = 0.0005 P = 0.032 P = 0.0056
a No. of years of experience in vascular radiology
Table 3 Duration of 2D, 3D, and S software analysis
Duration (s) IR-1 IR-2 IR-3 IR means
Number of
years of
experience in
vascular
radiology
(16)a (5) (5)
2D 113 102 67 94
3D 265 183 112 187
S 135
3D vs. 2D P \ 0.0001 P \ 0.0022 P \ 0.0001 P \ 0.0001
S vs. 2D P = 0.058 P \ 0.0001 P = 0.02 P \ 0.0001
S vs. 3D P \ 0.0001 P = 0.053 P = 0.0019 P \ 0.0001
a No. of years of experience in vascular radiology
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The time for using S seems compatible with real-time
use during TACE. Although use of S requires more time
than 2D image evaluation, it is more time efficient than
standard review of the 3D data set. Because S can be run by
XRTs, procedural time loss is limited. Thus, the IR can
continue working while the XRT uses S. Moreover, it is
noteworthy that compared with poor concordance of phy-
sician determination of FVs using 2D and 3D imaging, the
concordance between the XRTs who used S was high. In
addition, we observed no difference among XRTs of dif-
fering levels of experience regarding overall sensitivity or
time required to use S.
It should be emphasized that 2D and 3D analysis by
nonoperating IRs described in this study represents a less
stressful condition than when the same analysis would
occur during a procedure. It is possible, therefore, that the
intraprocedural benefits of S could be even more sub-
stantial than we have demonstrated.
No ‘‘gold standard’’ was available by which to assess the
accuracy of GT. GT only represented agreement among
three IRs using all available data. Because this was a retro-
spective study, FVs, as identified by GT, could not be tested
by selective angiography to test for true tumor supply.
Only visible vessels were taken into account. Thus,
noninjected vessels, such as collateral or parasitic arterial
supply from extrahepatic sources (e.g., the phrenic artery)
or tiny vessels, were naturally ignored by S even if they fed
the tumor.
S determined subsegmental FVs by a simple mathemat-
ical model: All regions of the parenchyma are perfused by
the vessel closest to them. Although using spatial proximity
as a surrogate for vascular connectivity in the liver has been
empirically validated [9], the possibility of attributing a
given parenchymal region (i.e., a voxel) to a nonfeeding
arterial branch exists. This could be solved through func-
tional imaging, e.g., by use of perfusion data. However, this
type of imaging is not typically used when planning or
performing TACE, whereas the entire anatomy (i.e.,
geometry) of the vascular tree can be extracted from global
angiograms. This explains why we used geometric distance
to approximately determine the perfusion relation between a
part of the vascular tree and a part of the hepatic
parenchyma.
Conclusion
Computed analysis software of 3D cone-beam CTA data
has a higher sensitivity in determining subsegmental FVs
than experienced IRs using 2D imaging alone. This anal-
ysis can be performed by an XRT, and processing time
appears compatible with real-time use during TACE. Pro-
spective evaluation of S in clinical practice is needed to
augment these findings.
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